Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 16, 2016 5:32pm
133 Views
Post# 24878704

RE:RE:RE:RE:RE:RE:RE:CD VENTURE IN TOP FIVE OF RVX SHAREHOLDERS?

RE:RE:RE:RE:RE:RE:RE:CD VENTURE IN TOP FIVE OF RVX SHAREHOLDERS?I find this CD Venture investment in RVX very interesting. Just the fact that it was never evident to date...and Sarah's response. And it seems there are possible Chinese roots and connections to this thread?

I'm not a trader so I don't understand that side but it does seem that slow accumulation has been happening for about 6 months. Slow accumulation would not impact a rise in the share price but obviously these people want a big chunk of the pie. From my point of view I understand why. If I had access to large pools of cash I'd be accumlating slowly to the largest position I could afford. When the stock hits $4.00 I'd take some profit and then sit tight for the futility results in 2017 and then for 2018 when this blockbuster hits the sky.

In the mean time the orphan trial and the prostate trial at Zenith could have very positive impacts.

CD Venture is there for a reason and I am sure they know far more than I know about RVX possibly through Hepalink! Who knows but great find on this information Jkj or GV...I can't quite remember who but please keep the detective work happening.

I sense that even though the trading is low and there seems to be little interest that there is a large pool of interest building in this (these) companies. IMHO

Toinv
Bullboard Posts